A Cancer Drug That Benefits People May Soon Benefit Man’s Best Friend

Published October 9, 2010

A Cancer Drug That Benefits People May Soon Benefit Man’s Best Friend
Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine, is the principal investigator in a study that examines the efficacy of Attaxol™ in dogs with naturally occurring cancer. Attaxol™ was developed, and is produced, by CritiTech, a Lawrence, Kan. drug development company. “Cancer is one of the most common causes of death in dogs,” Selting said…
Read more on Medical News Today

Drug patent row: seizure issue with EU resolved
India’s position accepted, patent rules to be amended to plug loopholes.
Read more on Business Standard India

Targeted therapy promising for HER2-positive metastatic breast cancer
( European Society for Medical Oncology ) A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology in Milan, Italy.
Read more on EurekAlert!